跳至主要内容
临床试验/NCT03009838
NCT03009838Unknown3 期

Letrozole Versus Laparoscopic Ovarian Drilling for Clomiphene-resistant Women With Polycystic Ovary Syndrome

Assiut University1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2017年1月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
150
试验地点
1
主要终点
The ovulation rate

研究概览

简要总结

Polycystic ovary syndrome is the major cause of anovulatory infertility. Clomiphene citrate is the most commonly used oral agent for ovulation induction in this group, but there are some drawbacks with the use of it.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • History of at least one year of infertility either primary or secondary.
  • Body mass index: 25-35
  • Normal fallopian tubes
  • Normal semen analysis of the husband
  • Women who will accept to participate in the study

排除标准

  • Body mass index above 35
  • Contraindication to general anesthesia
  • Previous laparoscopic drilling
  • Presence of other causes of infertility
  • Women who had received metformin, gonadotrophin, oral contraceptives or other hormonal drugs during the preceding 6 months
  • Women who intended to start a diet program
  • Women who will refuse to participate in the study.

研究组 & 干预措施

letrozole

Active Comparator

letrozole 2.5 mg oral tablets will be started daily from day 3 of the menses for 5 days in a dose of 5 mg/day

干预措施: Letrozole (Drug)

laparoscopic drilling

Active Comparator

laparoscopy will be performed using three-puncture technique. Each ovary will be cauterized at four points, each for 4 seconds at 40 W for a depth of 4 mm with a mixed current, using a monopolar electrosurgical needle

干预措施: ovarian drilling (Procedure)

结局指标

主要结局

The ovulation rate

时间窗: 3 months

次要结局

  • The mid-cyclic endometrial thickness(one day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohamed Abbas

Dr.

Assiut University

研究点 (1)

Loading locations...

相似试验